Durable Remissions with Control of Cytokine Release Syndrome (CRS) Using T Cells Expressing CD19 Targeted Chimeric Antigen Receptor (CAR) CTL019 to Treat Relapsed/Refractory (R/R) Acute Lymphoid Leukemia (ALL)
Levine, B.L, Maude, S, Zheng, Z, Shaw, P, Ambrose, D, Aplenc, R, Barker, C, Barrett, D, Brogdon, J, Callahan, C, Chen, F, Chew, A, Suhoski Davis, M.M, Fesnak, A.D, Finklestein, J, Frey, N, Lacey, S, Lamontagne, A, Lewitt, L, Loew, A, Marcucci, K, Melenhorst, J, Motley, L, Mudambi, M, Nazimuddin, F, O'Rourke, M, Porter, D, Rheingold, S.R, Scholler, J, Tayor, C, White, C, Wood, P, Young, R, Teachey, D.T, June, C, Grupp, S
Published in Cytotherapy (Oxford, England) (01.06.2016)
Published in Cytotherapy (Oxford, England) (01.06.2016)
Get full text
Journal Article
25 - Durable Remissions with Control of Cytokine Release Syndrome (CRS) Using T Cells Expressing CD19 Targeted Chimeric Antigen Receptor (CAR) CTL019 to Treat Relapsed/Refractory (R/R) Acute Lymphoid Leukemia (ALL)
Levine, B.L., Maude, S., Zheng, Z., Shaw, P., Ambrose, D., Aplenc, R., Barker, C., Barrett, D., Brogdon, J., Callahan, C., Chen, F., Chew, A., Suhoski Davis, M.M., Fesnak, A.D., Finklestein, J., Frey, N., Lacey, S., Lamontagne, A., Lewitt, L., Loew, A., Marcucci, K., Melenhorst, J., Motley, L., Mudambi, M., Nazimuddin, F., O'Rourke, M., Porter, D., Rheingold, S.R., Scholler, J., Tayor, C., White, C., Wood, P., Young, R., Teachey, D.T., June, C., Grupp, S.
Published in Cytotherapy (Oxford, England) (01.06.2016)
Published in Cytotherapy (Oxford, England) (01.06.2016)
Get full text
Journal Article